Polyglycolic Acid Market Share

  • Report ID: 4958
  • Published Date: Jun 28, 2024
  • Report Format: PDF, PPT

Polyglycolic Acid Market Share

North American Market Forecast

The polyglycolic acid market in North America is projected to dominate with a revenue share of about 37% by 2036. Growing cases of cardiac surgery and other surgeries are increasing the need for sutures and better drug delivery systems which in turn is likely to drive the market growth. Every year, around 500,000 open heart operations are conducted in the United States. In cardiac surgery, the sutures need to be dissolved themselves after the surgery for this purpose the polyglycolic acid sutures become increasingly important.

APAC Market Statistics

Asia Pacific polyglycolic acid market will be the second largest, gaining a share of nearly 26% by the end of 2036. Rising exploration operations and increased development of sedimentary rock gas extraction, such as shale gas. In 2021, around 23 million cubic meters of shale gas were produced in China, an increase of around 21% year on year since 2017. Polyglycolic acid is used in the formation of fracture plugs that are placed in the wellbore to isolate different shales and enable gas pipeline infrastructure for uninterrupted gas extraction.

Research Nester
Polyglycolic Acid Market size-min
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Rajrani Baghel


  • Report ID: 4958
  • Published Date: Jun 28, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of polyglycolic acid is evaluated at USD 4.8 Billion.

The polyglycolic acid market size was over USD 4.4 Billion in 2023 and is poised to cross USD 15.37 Billion by 2036, witnessing more than 10.1% CAGR during the forecast period i.e., between 2024-2036. Increasing demand for sustainable packaging, 3d printing, and medical sutures are the major factors driving the market growth.

North America industry is projected to dominate 37% revenue share by 2036, as growing cases of cardiac surgery and other surgeries are increasing the need for sutures and better drug delivery systems.

Kureha Corporation, Corbion NV, Shenzhen Polymtek Biomaterial Co. Ltd., BMG Incorporated, HuizhoForyou Medical Devices Co., Ltd., Teleflex Incorporated, Du Pont de Nemours, Inc., Foster Group, Inc., Samyang Holdings Biopharma Group, Ethicon Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample